BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8898005)

  • 1. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM; Jaffa AA; Margolius HS; Carey RM
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
    Siragy HM; Carey RM
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1103-7. PubMed ID: 9321892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism.
    Siragy HM; Lamb NE; Rose CE; Peach MJ; Carey RM
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F749-54. PubMed ID: 3052111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model.
    Siragy HM; Carey RM
    Hypertension; 1999 May; 33(5):1237-42. PubMed ID: 10334818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II does not increase renal prostaglandin E2 in response to pressure reduction.
    Imanishi M; Akabane S; Kawamura M; Matsushima Y; Kuramochi M; Omae T
    Kidney Int; 1992 Aug; 42(2):417-23. PubMed ID: 1405324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.
    Siragy HM; Ibrahim MM; Jaffa AA; Mayfield R; Margolius HS
    Hypertension; 1994 Jun; 23(6 Pt 2):1068-70. PubMed ID: 8206596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intrarenal ANG II in reflex neural stimulation of plasma renin activity and renal sodium reabsorption.
    Nelson LD; Osborn JL
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R392-8. PubMed ID: 8368393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F522-9. PubMed ID: 2180318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
    Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
    Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
    Munger KA; Jackson EK
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep.
    Stevenson KM; Gibson KJ; Lumbers ER
    Clin Exp Pharmacol Physiol; 1996 Feb; 23(2):125-33. PubMed ID: 8819640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM; Jaffa AA; Margolius HS
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ; Kladis A; Valentijn AJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.